Status: Not yet recruiting
VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)
Pivotal trial to evaluate the safety and clinical efficacy of the VDyne System for the treatment of symptomatic severe or greater tricuspid regurgitation.
Participants needed: 730
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: VDyne, Inc.Updated: Apr 8, 2026
Eligibility criteria
Age ≥18 years old [+7]
Subject unable or unwilling to comply with study required testing and follow-up... [+17]